Patent ID: 11897927
Assignee: ADVAXIS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 49:
50. The recombinant Listeria strain of claim 49, wherein:
(a) the fusion polypeptide comprises the sequence set forth in any one of SEQ ID NOS: 859, 860, 861, 862, 863, 864, 865, 894, 895, and 905;
(b) the fusion polypeptide comprises the sequence set forth in any one of SEQ ID NOS: 871, 872 873, 874, 875, 876, 877, 892, 893, and 906;
(c) the fusion polypeptide comprises the sequence set forth in any one of SEQ ID NOS: 866, 867, 868, 869, 870, and 908;
(d) the fusion polypeptide comprises the sequence set forth in any one of SEQ ID NOS: 878, 879, 880, 881, 882, 888, 889, 890, and 891;
(e) the fusion polypeptide comprises the sequence set forth in any one of SEQ ID NOS: 883, 884, 885, 886, 887, and 907;
(f) the fusion polypeptide comprises the sequence set forth in any one of SEQ ID NOS: 896, 897, and 904;
(g) the fusion polypeptide comprises the sequence set forth in any one of SEQ ID NOS: 898 and 899;
(h) the fusion polypeptide comprises the sequence set forth in any one of SEQ ID NOS: 900 and 901;
(i) the fusion polypeptide comprises the sequence set forth in any one of SEQ ID NOS: 902 and 903; or
(j) the fusion polypeptide comprises the sequence set forth in any one of SEQ ID NOS: 918 and 919.